delafloxacin

Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Endpoints
Mon, 06/19/17 - 11:35 pm
Melinta Therapeutics
FDA
antibiotics
delafloxacin
Baxdela
Antibiotics developer Melinta lands a $70M round for PhIII development
Fierce Biotech
Mon, 02/10/14 - 05:48 pm
Melinta Therapeutics
antibiotics
delafloxacin
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Wed, 10/9/13 - 03:58 pm
Merck
Pfizer
Eli Lilly
Big Pharma
Sanofi
Roche
GSK
Abbott Laboratories
Melinta Therapeutics
antibiotics
delafloxacin
Rib-X touts positive PhIIb antibiotic data
Fierce Biotech
Thu, 12/15/11 - 07:35 pm
antibiotics
Rib-X Pharmaceuticals
delafloxacin